(Q45867420)

17 December 2017

title

Synergy of adoptive T-cell therapy and intratumoral suicide gene therapy is mediated by host NK cells (English)

1 reference

17 December 2017

0 references

2

1 reference

17 December 2017

author name string

Sanchez-Perez L

1

1 reference

17 December 2017

Qiao J

3

1 reference

17 December 2017

Thanarajasingam U

4

1 reference

17 December 2017

Kottke T

5

1 reference

17 December 2017

Ahmed A

6

1 reference

17 December 2017

Thompson JM

7

1 reference

17 December 2017

Maria Diaz R

8

1 reference

17 December 2017

Vile RG

9

1 reference

17 December 2017

publication date

19 April 2007

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

14

1 reference

17 December 2017

page(s)

998-1009

1 reference

17 December 2017

issue

13

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302935

exact match

0 references

cites work

Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Cancer regression in patients after transfer of genetically engineered lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Adoptive-cell-transfer therapy for the treatment of patients with cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Immunosuppressive networks in the tumour environment and their therapeutic relevance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Generation of an anti-tumour immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoural cytokine expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Immune system in suicide-gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Characterization of the antitumor immune response generated by treatment of murine tumors with recombinant adenoviruses expressing HSVtk, IL-2, IL-6 or B7-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Gene therapy for malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Hurdles to lymphocyte trafficking in the tumor microenvironment: implications for effective immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

The perforin-dependent immunological synapse allows T-cell activation-dependent tumor targeting by MLV vector particles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Cancer gene therapy: fringe or cutting edge?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

T cell receptor antagonist peptides induce positive selection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Eradication of established tumors by CD8+ T cell adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Apoptosis or necrosis for tumor immunotherapy: what's in a name?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

Activation of NK cell cytotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.GT.3302935

1 reference

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302935

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017